These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22769591)

  • 1. Analysis of the tau-associated proteome reveals that exchange of Hsp70 for Hsp90 is involved in tau degradation.
    Thompson AD; Scaglione KM; Prensner J; Gillies AT; Chinnaiyan A; Paulson HL; Jinwal UK; Dickey CA; Gestwicki JE
    ACS Chem Biol; 2012 Oct; 7(10):1677-86. PubMed ID: 22769591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp multichaperone complex buffers pathologically modified Tau.
    Moll A; Ramirez LM; Ninov M; Schwarz J; Urlaub H; Zweckstetter M
    Nat Commun; 2022 Jun; 13(1):3668. PubMed ID: 35760815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
    Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
    J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.
    Miyata Y; Koren J; Kiray J; Dickey CA; Gestwicki JE
    Future Med Chem; 2011 Sep; 3(12):1523-37. PubMed ID: 21882945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilizing the Hsp70-Tau Complex Promotes Turnover in Models of Tauopathy.
    Young ZT; Rauch JN; Assimon VA; Jinwal UK; Ahn M; Li X; Dunyak BM; Ahmad A; Carlson GA; Srinivasan SR; Zuiderweg ER; Dickey CA; Gestwicki JE
    Cell Chem Biol; 2016 Aug; 23(8):992-1001. PubMed ID: 27499529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp90 activator Aha1 drives production of pathological tau aggregates.
    Shelton LB; Baker JD; Zheng D; Sullivan LE; Solanki PK; Webster JM; Sun Z; Sabbagh JJ; Nordhues BA; Koren J; Ghosh S; Blagg BSJ; Blair LJ; Dickey CA
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9707-9712. PubMed ID: 28827321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low endogenous and chemical induced heat shock protein induction in a 0N3Rtau-expressing Drosophila larval model of Alzheimer's disease.
    Sinadinos C; Quraishe S; Sealey M; Samson PB; Mudher A; Wyttenbach A
    J Alzheimers Dis; 2013; 33(4):1117-33. PubMed ID: 23114515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the Hsp90 cochaperone cyclophilin 40 with Hsc70.
    Carrello A; Allan RK; Morgan SL; Owen BA; Mok D; Ward BK; Minchin RF; Toft DO; Ratajczak T
    Cell Stress Chaperones; 2004; 9(2):167-81. PubMed ID: 15497503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
    Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
    Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking HSP90 target occupancy to HSP70 induction and efficacy in mouse brain.
    Thirstrup K; Sotty F; Montezinho LC; Badolo L; Thougaard A; Kristjánsson M; Jensen T; Watson S; Nielsen SM
    Pharmacol Res; 2016 Feb; 104():197-205. PubMed ID: 26731018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp90-Tau complex reveals molecular basis for specificity in chaperone action.
    Karagöz GE; Duarte AM; Akoury E; Ippel H; Biernat J; Morán Luengo T; Radli M; Didenko T; Nordhues BA; Veprintsev DB; Dickey CA; Mandelkow E; Zweckstetter M; Boelens R; Madl T; Rüdiger SG
    Cell; 2014 Feb; 156(5):963-74. PubMed ID: 24581495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport.
    Patterson KR; Ward SM; Combs B; Voss K; Kanaan NM; Morfini G; Brady ST; Gamblin TC; Binder LI
    Biochemistry; 2011 Nov; 50(47):10300-10. PubMed ID: 22039833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp90-interacting Co-chaperones and their Family Proteins in Tau Regulation: Introducing a Novel Role for Cdc37L1.
    Peak SL; Gracia L; Lora G; Jinwal UK
    Neuroscience; 2021 Jan; 453():312-323. PubMed ID: 33246057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies.
    Luo W; Dou F; Rodina A; Chip S; Kim J; Zhao Q; Moulick K; Aguirre J; Wu N; Greengard P; Chiosis G
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9511-6. PubMed ID: 17517623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat Shock Proteins in Alzheimer's Disease: Role and Targeting.
    Campanella C; Pace A; Caruso Bavisotto C; Marzullo P; Marino Gammazza A; Buscemi S; Palumbo Piccionello A
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp70 alters tau function and aggregation in an isoform specific manner.
    Voss K; Combs B; Patterson KR; Binder LI; Gamblin TC
    Biochemistry; 2012 Jan; 51(4):888-98. PubMed ID: 22236337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau triage decisions mediated by the chaperone network.
    Cook C; Petrucelli L
    J Alzheimers Dis; 2013; 33 Suppl 1():S145-51. PubMed ID: 22596270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DnaJA1 antagonizes constitutive Hsp70-mediated stabilization of tau.
    Abisambra JF; Jinwal UK; Suntharalingam A; Arulselvam K; Brady S; Cockman M; Jin Y; Zhang B; Dickey CA
    J Mol Biol; 2012 Aug; 421(4-5):653-61. PubMed ID: 22343013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.
    Jinwal UK; Trotter JH; Abisambra JF; Koren J; Lawson LY; Vestal GD; O'Leary JC; Johnson AG; Jin Y; Jones JR; Li Q; Weeber EJ; Dickey CA
    J Biol Chem; 2011 May; 286(19):16976-83. PubMed ID: 21367866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated neurodegeneration through chaperone-mediated oligomerization of tau.
    Blair LJ; Nordhues BA; Hill SE; Scaglione KM; O'Leary JC; Fontaine SN; Breydo L; Zhang B; Li P; Wang L; Cotman C; Paulson HL; Muschol M; Uversky VN; Klengel T; Binder EB; Kayed R; Golde TE; Berchtold N; Dickey CA
    J Clin Invest; 2013 Oct; 123(10):4158-69. PubMed ID: 23999428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.